Description
Teneligliptin Tablets
• Product Overview
Teneligliptin Tablets are oral antidiabetic medicines belonging to the DPP-4 (Dipeptidyl Peptidase-4) inhibitor class. They are used to improve glycemic control in adults with Type 2 Diabetes Mellitus by increasing incretin hormone levels, which enhance glucose-dependent insulin secretion and suppress glucagon release. Teneligliptin may be used alone or in combination with other antidiabetic medications as part of an effective diabetes management program.
• Available Strengths
– Teneligliptin 20 mg Tablets
– Teneligliptin 40 mg Tablets
• Therapeutic Category
Oral Antidiabetic (DPP-4 Inhibitor)
• Indications
Teneligliptin Tablets are indicated for the management of:
– Type 2 Diabetes Mellitus
– Blood glucose control in combination with diet and exercise
– Monotherapy (when appropriate)
– Combination therapy with Metformin, Sulfonylureas, SGLT2 inhibitors, Thiazolidinediones, or Insulin
• Common Side Effects
Some patients may experience:
– Headache
– Dizziness
– Nasopharyngitis (common cold symptoms)
– Constipation
– Nausea
– Mild hypoglycemia (especially in combination therapy)
• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Severe allergic reactions (Anaphylaxis)
– Pancreatitis (severe abdominal pain)
– Severe skin reactions
– Angioedema (swelling of the face, lips, tongue, or throat)
– Severe joint pain
– Hypoglycemia (particularly when used with insulin or sulfonylureas)
• Precautions
– Use only under the supervision of a healthcare professional.
– Monitor blood glucose levels regularly.
– Not indicated for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
– Inform your healthcare provider if you have a history of pancreatitis.
– Use cautiously in patients with kidney or liver impairment.
– Consult a healthcare professional before use during pregnancy or breastfeeding.
– Store below 30°C in a cool, dry place away from moisture and direct sunlight.
• Technical Information
• Active Ingredient
Teneligliptin
• Mechanism of Action
Teneligliptin inhibits the DPP-4 enzyme, increasing incretin hormone levels, which stimulate glucose-dependent insulin secretion and reduce glucagon secretion, helping to maintain optimal blood glucose control.
• Dosage Form
Tablet
• Route of Administration
Oral
• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)
• Storage Conditions
Store below 30°C in a dry place protected from moisture and direct sunlight.
• Product Specifications
Product Name:- Teneligliptin Tablets
Generic Name:- Teneligliptin
Strengths:- 20 mg, 40 mg
Dosage Form:- Tablet
Category:- Oral Antidiabetic (DPP-4 Inhibitor)
Packaging:- Blister / Alu-Alu / Customized Export Packing
Shelf Life:- 24–36 Months
Storage:- Below 30°C
Origin:- India
• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international export markets.
– Export documentation support available.
– Private Label Manufacturing available.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Bulk quantities available for distributors, wholesalers, hospitals, pharmacies, and government tenders.
• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Pharmaceutical Distributors
– Medicine Wholesalers
– Hospital Procurement Companies
– Pharmacy Chains
– Diabetes Care Clinics
– Government Procurement Agencies
– Tender Suppliers
– Private Label Brands
• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– Competitive International Pricing
– WHO-GMP Manufacturing Partners
– Wide Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Timely Delivery
– Complete Export Documentation Support
– Dedicated Customer Support
• Contact Details
Mediora Exports
📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844
For product inquiries, quotations, distributorship opportunities, private labeling, and bulk export orders, please contact our team.
Reviews
There are no reviews yet.